298 related articles for article (PubMed ID: 12653748)
21. Troglitazone suppresses transforming growth factor-beta1-induced collagen type I expression in keloid fibroblasts.
Zhang GY; Yi CG; Li X; Ma B; Li ZJ; Chen XL; Guo SZ; Gao WY
Br J Dermatol; 2009 Apr; 160(4):762-70. PubMed ID: 19120328
[TBL] [Abstract][Full Text] [Related]
22. Keloid fibroblasts are more sensitive to Wnt3a treatment in terms of elevated cellular growth and fibronectin expression.
Chua AW; Gan SU; Ting Y; Fu Z; Lim CK; Song C; Sabapathy K; Phan TT
J Dermatol Sci; 2011 Dec; 64(3):199-209. PubMed ID: 22005028
[TBL] [Abstract][Full Text] [Related]
23. DHMEQ, a novel NF-kappaB inhibitor, suppresses growth and type I collagen accumulation in keloid fibroblasts.
Makino S; Mitsutake N; Nakashima M; Saenko VA; Ohtsuru A; Umezawa K; Tanaka K; Hirano A; Yamashita S
J Dermatol Sci; 2008 Sep; 51(3):171-80. PubMed ID: 18406579
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin-converting enzyme (ACE) inhibition attenuates insulin-like growth factor-I (IGF-I) induced cardiac fibroblast proliferation.
van Eickels M; Vetter H; Grohé C
Br J Pharmacol; 2000 Dec; 131(8):1592-6. PubMed ID: 11139436
[TBL] [Abstract][Full Text] [Related]
25. Modulation of caveolin-1 expression can affect signalling through the phosphatidylinositol 3-kinase/Akt pathway and cellular proliferation in response to insulin-like growth factor I.
Matthews LC; Taggart MJ; Westwood M
Endocrinology; 2008 Oct; 149(10):5199-208. PubMed ID: 18583416
[TBL] [Abstract][Full Text] [Related]
26. Genistein inhibits insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells: a possible mechanism of the growth inhibitory effect of Genistein.
Kim EJ; Shin HK; Park JH
J Med Food; 2005; 8(4):431-8. PubMed ID: 16379552
[TBL] [Abstract][Full Text] [Related]
27. A study of the combination of triamcinolone and 5-fluorouracil in modulating keloid fibroblasts in vitro.
Huang L; Cai YJ; Lung I; Leung BC; Burd A
J Plast Reconstr Aesthet Surg; 2013 Sep; 66(9):e251-9. PubMed ID: 23810214
[TBL] [Abstract][Full Text] [Related]
28. Sorafenib exerts an anti-keloid activity by antagonizing TGF-β/Smad and MAPK/ERK signaling pathways.
Wang W; Qu M; Xu L; Wu X; Gao Z; Gu T; Zhang W; Ding X; Liu W; Chen YL
J Mol Med (Berl); 2016 Oct; 94(10):1181-1194. PubMed ID: 27339758
[TBL] [Abstract][Full Text] [Related]
29. Expression of insulin-like growth factor-1 receptor in keloid and hypertrophic scar.
Hu ZC; Tang B; Guo D; Zhang J; Liang YY; Ma D; Zhu JY
Clin Exp Dermatol; 2014 Oct; 39(7):822-8. PubMed ID: 25154292
[TBL] [Abstract][Full Text] [Related]
30. Influence of quercetin and x-ray on collagen synthesis of cultured human keloid-derived fibroblasts.
Long X; Zeng X; Zhang FQ; Wang XJ
Chin Med Sci J; 2006 Sep; 21(3):179-83. PubMed ID: 17086741
[TBL] [Abstract][Full Text] [Related]
31. Increased periostin expression affects the proliferation, collagen synthesis, migration and invasion of keloid fibroblasts under hypoxic conditions.
Zhang Z; Nie F; Kang C; Chen B; Qin Z; Ma J; Ma Y; Zhao X
Int J Mol Med; 2014 Jul; 34(1):253-61. PubMed ID: 24788198
[TBL] [Abstract][Full Text] [Related]
32. mTOR as a potential therapeutic target for treatment of keloids and excessive scars.
Ong CT; Khoo YT; Mukhopadhyay A; Do DV; Lim IJ; Aalami O; Phan TT
Exp Dermatol; 2007 May; 16(5):394-404. PubMed ID: 17437482
[TBL] [Abstract][Full Text] [Related]
33. Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts.
Takahashi Y; Tobe K; Kadowaki H; Katsumata D; Fukushima Y; Yazaki Y; Akanuma Y; Kadowaki T
Endocrinology; 1997 Feb; 138(2):741-50. PubMed ID: 9003010
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic effect of interleukin-10 in keloid fibroblasts by suppression of TGF-β/Smad pathway.
Shi CK; Zhao YP; Ge P; Huang GB
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):9085-9092. PubMed ID: 31696499
[TBL] [Abstract][Full Text] [Related]
35. The mechanism of butyrate-induced collagen biosynthesis in cultured fibroblasts.
Karna E; Trojan S; Pałka JA
Acta Pol Pharm; 2009; 66(3):229-33. PubMed ID: 19645322
[TBL] [Abstract][Full Text] [Related]
36. IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells.
Fleming JM; Leibowitz BJ; Kerr DE; Cohick WS
J Endocrinol; 2005 Jul; 186(1):165-78. PubMed ID: 16002546
[TBL] [Abstract][Full Text] [Related]
37. Extract of Aneilema keisak inhibits transforming growth factor-β-dependent signalling by inducing Smad2 downregulation in keloid fibroblasts.
Kim WS; Lee JS; Bae GY; Kim JJ; Chin YW; Bahk YY; Min HG; Cha HJ
Exp Dermatol; 2013 Jan; 22(1):69-71. PubMed ID: 23278899
[TBL] [Abstract][Full Text] [Related]
38. A novel truncated TGF-beta receptor II downregulates collagen synthesis and TGF-beta I secretion of keloid fibroblasts.
Chu Y; Guo F; Li Y; Li X; Zhou T; Guo Y
Connect Tissue Res; 2008; 49(2):92-8. PubMed ID: 18382895
[TBL] [Abstract][Full Text] [Related]
39. Ginsenoside Rg3 inhibits keloid fibroblast proliferation, angiogenesis and collagen synthesis in vitro via the TGF‑β/Smad and ERK signaling pathways.
Tang M; Bian W; Cheng L; Zhang L; Jin R; Wang W; Zhang Y
Int J Mol Med; 2018 Mar; 41(3):1487-1499. PubMed ID: 29328420
[TBL] [Abstract][Full Text] [Related]
40. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
Guvakova MA; Surmacz E
Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
